Trademark Search

ENCELTO

View On IPO.GOV.AU

Protected: Registered/protected

Last updated on 1 Dec 2023

Owner Info

Neurotech Pharmaceuticals, Inc.

900 Highland Corporate Drive, Suite 101

Cumberland RI 02864, UNITED STATES OF AMERICA

Serial Number

2377112 filed on 3 Jul 2023

Correspondent

Emilia F. Cannella Ropes & Gray LLP

Prudential Tower,,

800 Boylston Street,

UNITED STATES OF AMERICA

ENCELTO

Classification Information

Class [005]
Intravitreal implants containing a pharmaceutical for the treatment of eye and vision conditions.

Class [010]
Medical device, namely, intraocular implant.

Mark Details

Serial Number

2377112

Registered On

3 Jul 2023

Renewal On

3 Jul 2033

Mark Type

WORD

Priority Claim (Convention Details)

Date

4 Jan 2023

Mark Type

Legal History

Status Date	Action Taken
1^st Dec 2023	Customer Amendment Made correspondence sent
1^st Dec 2023	Amendment to Address for Service Requested
13^th Oct 2023	International Registration in Australia Protected correspondence sent
11^th Oct 2023	IP Right Registration Published
11^th Oct 2023	Status change to Registered/Protected
5^th Aug 2023	Application Accepted correspondence sent
4^th Aug 2023	IP Right has been Examined
4^th Aug 2023	IP Right Acceptance Published
4^th Aug 2023	Status change to Accepted
3^rd Aug 2023	Awaiting examination

ENCELTO

Classification Information

Class [005]Intravitreal implants containing a pharmaceutical for the treatment of eye and vision conditions.

Class [010]Medical device, namely, intraocular implant.

Mark Details

Serial Number

Registered On

Renewal On

Mark Type

Priority Claim (Convention Details)

Date

Mark Type

Legal History

Class [005]
Intravitreal implants containing a pharmaceutical for the treatment of eye and vision conditions.

Class [010]
Medical device, namely, intraocular implant.